Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 679237, 4 pages
http://dx.doi.org/10.1155/2008/679237
Review Article

Role of Peoxisome Proliferator Activator Receptor 𝛾 on Blood Retinal Barrier Breakdown

Department of Ophthalmology, School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Received 24 May 2007; Accepted 10 July 2007

Academic Editor: Suofu Qin

Copyright © 2008 Yasuo Yanagi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Moss, R. Klein, and B. E. Klein, “The 14-year incidence of visual loss in a diabetic population,” Ophthalmology, vol. 105, no. 6, pp. 998–1003, 1998. View at Publisher · View at Google Scholar
  2. J.-F. Angers and A. Biswas, “A Bayesian analysis of the 4-year follow-up data of the Wilconsin epidemiologic study of diabetic retinopathy,” Statistics in Medicine, vol. 23, no. 4, pp. 601–615, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. G. M. Comer and T. A. Ciulla, “Pharmacotherapy for diabetic retinopathy,” Current Opinion in Ophthalmology, vol. 15, no. 6, pp. 508–518, 2004. View at Publisher · View at Google Scholar
  4. R. Grigorian, N. Bhagat, P. Lanzetta, A. Tutela, and M. Zarbin, “Pars plana vitrectomy for refractory diabetic macular edema,” Seminars in Ophthalmology, vol. 18, no. 3, pp. 116–120, 2003. View at Publisher · View at Google Scholar · View at PubMed
  5. E. T. Cunningham, Jr., A. P. Adamis, M. Altaweel et al., “A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema,” Ophthalmology, vol. 112, no. 10, pp. 1747–1757, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. C. Haritoglou, D. Kook, A. Neubauer et al., “Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema,” Retina, vol. 26, no. 9, pp. 999–1005, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. K. Miyamoto and Y. Ogura, “Pathogenetic potential of leukocytes in diabetic retinopathy,” Seminars in Ophthalmology, vol. 14, no. 4, pp. 233–239, 1999. View at Google Scholar
  9. D. S. McLeod, D. J. Lefer, C. Merges, and G. A. Lutty, “Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid,” American Journal of Pathology, vol. 147, no. 3, pp. 642–653, 1995. View at Google Scholar
  10. H. Funatsu, H. Yamashita, T. Ikeda, T. Mimura, S. Eguchi, and S. Hori, “Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema,” Ophthalmology, vol. 110, no. 9, pp. 1690–1696, 2003. View at Publisher · View at Google Scholar · View at PubMed
  11. K. Miyamoto, S. Khosrof, S.-E. Bursell et al., “Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10836–10841, 1999. View at Publisher · View at Google Scholar
  12. A. M. Joussen, V. Poulaki, W. Qin et al., “Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo,” American Journal of Pathology, vol. 160, no. 2, pp. 501–509, 2002. View at Google Scholar
  13. K. Miyamoto, S. Khosrof, S.-E. Bursell et al., “Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1),” American Journal of Pathology, vol. 156, no. 5, pp. 1733–1739, 2000. View at Google Scholar
  14. A. M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S.-E. Bursell, and A. P. Adamis, “Leukocyte-mediated endothelial cell injury and death in the diabetic retina,” American Journal of Pathology, vol. 158, no. 1, pp. 147–152, 2001. View at Google Scholar
  15. A. Nakajima, K. Wada, H. Miki et al., “Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury,” Gastroenterology, vol. 120, no. 2, pp. 460–469, 2001. View at Publisher · View at Google Scholar
  16. W. Chen, W. J. Esselman, D. B. Jump, and J. V. Busik, “Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells,” Investigative Ophthalmology & Visual Science, vol. 46, no. 11, pp. 4342–4347, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression,” The FASEB Journal, vol. 16, no. 3, pp. 438–440, 2002. View at Publisher · View at Google Scholar · View at PubMed
  18. E. D. Rosen and B. M. Spiegelman, “PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth,” Journal of Biological Chemistry, vol. 276, no. 41, pp. 37731–37734, 2001. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Okada, S. F. Yan, and D. J. Pinsky, “Peroxisome proliferator-activated receptor-γ (PPARγ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets,” The FASEB Journal, vol. 16, no. 14, pp. 1861–1868, 2002. View at Publisher · View at Google Scholar · View at PubMed
  20. V. Pasceri, H. D. Wu, J. T. Willerson, and E. T. Yeh, “Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators,” Circulation, vol. 101, no. 3, pp. 235–238, 2000. View at Google Scholar
  21. C. Wang, M. Fu, M. D'Amico et al., “Inhibition of cellular proliferation through IκB kinase-independent and peroxisome proliferator-activated receptor γ-dependent repression of cyclin D1,” Molecular and Cellular Biology, vol. 21, no. 9, pp. 3057–3070, 2001. View at Publisher · View at Google Scholar · View at PubMed
  22. K. Muranaka, Y. Yanagi, Y. Tamaki et al., “Effects of peroxisome proliferator-activated receptor γ and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model,” Investigative Ophthalmology & Visual Science, vol. 47, no. 10, pp. 4547–4552, 2006. View at Publisher · View at Google Scholar · View at PubMed